Use access key #2 to skip to page content.
$39.00 3.92 (11.17%)
10/13/2008 4:05 PM

GlaxoSmithKline plc (ADR) (GSK)

CAPS Rating:
****

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

View Ticker Page (GSK)

Results 21 - 30 of 172 :   12345Next »

Recs

1

Avatar strider888 (< 20) Submitted: 11/25/07 12:14 AM : Outperform Start Price: $49.53 GSK Score: 16.47

New fat reduction drug on sale now will surprise all analysts. This is a $100 stock by 2009

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar Longylala (89.04) Submitted: 5/29/07 7:51 PM : Outperform Start Price: $47.80 GSK Score: 22.21

With the recent news about Avandia, the short term prospects are not very good. However, with their new line of products, including Alli, they should recover and regain investor confidence.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar Godwynn (84.60) Submitted: 5/21/07 1:04 PM : Outperform Start Price: $51.01 GSK Score: 17.69

Beaten down by a study saying its drug Avandia causes an increase in the risk for heart attack.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar Tak3natheFlood (93.56) Submitted: 9/25/08 7:48 PM : Underperform Start Price: $44.86 GSK Score: -11.24

I see many downsides to this pharmaceutical. The company is shrinking with free cash flows suffering. A Democratic government will not be friendly to prescription drug companies in the future. Any new developments don't help the bottom line unless th...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar sailor175 (< 20) Submitted: 9/22/06 9:16 PM : Outperform Start Price: $50.19 GSK Score: 9.38

EPS 06growth 6%, 07 growth 14%.
Strong pipeline of 150 drugs , 25 in phase 3.
For conservative movers. Not exciting but with safe steady growth

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar CelticAces (< 20) Submitted: 2/15/08 1:50 AM : Outperform Start Price: $43.02 GSK Score: 23.81

Buffet just picked some up today. Where Buffet goes, the market follows

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar paka3517 (< 20) Submitted: 5/14/07 1:49 PM : Outperform Start Price: $53.67 GSK Score: 12.88

New drugs, they are a comin.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar dplindeman (98.73) Submitted: 4/25/07 12:59 PM : Outperform Start Price: $55.15 GSK Score: 10.27

GOOD PHARM COMPANY WITHOUT THE NEGATIVE INERTIA PLAGUING MERCK AND PFIZER. LOOK FOR A GOOD RUN

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar iamamartin (99.41) Submitted: 10/13/06 10:45 AM : Outperform Start Price: $50.01 GSK Score: 11.91

More old people = more drug sales.
Baby Boomer Demographics !

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar martynanasi (99.25) Submitted: 11/09/06 12:20 PM : Outperform Start Price: $50.21 GSK Score: 11.07

Glaxo is one of the better run big Pharma. Good management. Pipeline could use a boost but expect them to acquire biotechs in the coming future.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners